<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: We attempted to assess whether <z:mp ids='MP_0002959'>microalbuminuria</z:mp> conferred the same cardiovascular risk as overt <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> in type 2 diabetic patients </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: A prospective cohort study including 436 type 2 diabetic patients (64.8+/-9.2 years old) without <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, with follow-up until any cardiovascular event occurred, was performed </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were classified into four groups: group 0, non baseline <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and normoalbuminuria; group 1, non baseline <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp>; group 2, baseline <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and normoalbuminuria; group 3, baseline <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Cox's multivariate regression models were used to assess the risk ratio (RR) associated with each variable </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The median follow-up time was 7.6 years </plain></SENT>
<SENT sid="5" pm="."><plain>Incidence rates of cardiovascular events per 1000 patient-years increased from groups 0 to 3 (23.8, 63.4, 74.1, 85.6; p&lt;0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariate RR for incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> in groups 1, 2 and 3 in relation to group 0 were 2.8 (95% confidence interval (CI) 1.7-4.6; p&lt;0.0001), 2.7 (95% CI 1.6-4.6; p&lt;0.0001) and 2.9 (95% CI 1.6-5.4; p=0.001), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>No significant differences were seen between groups 1 and 2 </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: We suggest that patients with <z:mp ids='MP_0002959'>microalbuminuria</z:mp> are at very high vascular risk and should share the same objectives of a vascular risk-factor control as patients with overt <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
</text></document>